JHPCYJIANGSU HENGRUI PHARMACEUTICALS CO LTD

About JIANGSU HENGRUI PHARMACEUTICALS CO LTD (JHPCY)

JIANGSU HENGRUI PHARMACEUTICALS CO LTD (JHPCY) is a N/A company headquartered in Lianyungang, Jiangsu, China whose shares trade over-the-counter on the Pink tier.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. ("Hengrui") is a leading global pharmaceutical company headquartered in China with a focus on research, development, manufacturing, and commercialization of innovative and high-quality healthcare products. The Company has focused its R&D efforts on oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. Hengrui has been on Pharma Exec's annual listing of the global Top 50 pharmaceutical companies for six consecutive years since 2019. Hengrui ranked 8th on the list of "Top 25 Global Pharma Companies by Pipeline Size" published by Citeline in 2024.

JHPCY key facts

Ticker symbol

JHPCY

Market tier

Pink

Headquarters

Lianyungang, Jiangsu, China

Shares outstanding

258,197,600

Reporting standard

International Reporting: Hong Kong Stock Exchange

Audit status

Not Available

Explore more: Pink stocks · OTC stocks starting with J